Zhejiang Jingxin Pharmaceutical Co Ltd Working Capital to Net Assets Ratio

Latest as of June 2026: 38.5%

Zhejiang Jingxin Pharmaceutical Co Ltd working capital to net assets ratio. Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Working Capital to Net Assets ratio of 38.5% as of June 2026. Working capital of CN¥2.32 Billion (current assets of CN¥3.89 Billion minus current liabilities of CN¥1.57 Billion) is measured against net assets of CN¥6.04 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Zhejiang Jingxin Pharmaceutical Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

38.5%
Working Capital / Net Assets

Working Capital

CN¥2.32 Billion
CNY

Current Assets

CN¥3.89 Billion
CNY

Current Liabilities

CN¥1.57 Billion
CNY

Working Capital to Net Assets Ratio of Zhejiang Jingxin Pharmaceutical Co Ltd (2001–2025)

Working capital to net assets ratio of Zhejiang Jingxin Pharmaceutical Co Ltd from 2001 to 2025. This chart shows how Zhejiang Jingxin Pharmaceutical Co Ltd's Working Capital to Net Assets ratio has evolved across 25 annual periods from 2001 to 2025. As of June 2026, the ratio stands at 38.5%, reflecting working capital of CN¥2.32 Billion against net assets of CN¥6.04 Billion CNY. See operational self-sufficiency of Zhejiang Jingxin Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.

Zhejiang Jingxin Pharmaceutical Co Ltd Working Capital to Net Assets Ratio by Year (2001–2025)

Zhejiang Jingxin Pharmaceutical Co Ltd working capital to net assets ratio by year from 2001 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Zhejiang Jingxin Pharmaceutical Co Ltd from 2001 to 2025, covering 25 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Zhejiang Jingxin Pharmaceutical Co Ltd's balance sheet.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2025 23.7% CN¥1.39 Billion CN¥5.87 Billion CN¥3.30 Billion CN¥1.91 Billion ▲ +10.9 pp
2024 12.8% CN¥770.26 Million CN¥6.00 Billion CN¥2.90 Billion CN¥2.13 Billion ▼ -10.3 pp
2023 23.1% CN¥1.28 Billion CN¥5.54 Billion CN¥3.35 Billion CN¥2.07 Billion ▼ -5.3 pp
2022 28.3% CN¥1.47 Billion CN¥5.17 Billion CN¥3.28 Billion CN¥1.82 Billion ▼ -9.8 pp
2021 38.1% CN¥1.84 Billion CN¥4.84 Billion CN¥3.23 Billion CN¥1.39 Billion ▼ -2.0 pp
2020 40.1% CN¥1.58 Billion CN¥3.93 Billion CN¥3.13 Billion CN¥1.55 Billion ▼ -6.1 pp
2019 46.2% CN¥1.71 Billion CN¥3.71 Billion CN¥3.49 Billion CN¥1.77 Billion ▼ -1.2 pp
2018 47.4% CN¥1.69 Billion CN¥3.57 Billion CN¥3.04 Billion CN¥1.34 Billion ▼ -6.2 pp
2017 53.6% CN¥2.13 Billion CN¥3.97 Billion CN¥3.00 Billion CN¥869.40 Million ▲ +22.1 pp
2016 31.5% CN¥764.52 Million CN¥2.43 Billion CN¥1.56 Billion CN¥798.36 Million ▼ -4.6 pp
2015 36.1% CN¥816.29 Million CN¥2.26 Billion CN¥1.43 Billion CN¥616.98 Million ▼ -2.2 pp
2014 38.3% CN¥535.56 Million CN¥1.40 Billion CN¥1.14 Billion CN¥604.00 Million ▲ +25.7 pp
2013 12.6% CN¥102.70 Million CN¥817.98 Million CN¥556.75 Million CN¥454.05 Million ▼ -8.8 pp
2012 21.4% CN¥165.00 Million CN¥772.58 Million CN¥625.62 Million CN¥460.62 Million ▼ -7.1 pp
2011 28.4% CN¥217.93 Million CN¥766.17 Million CN¥573.43 Million CN¥355.50 Million ▲ +25.5 pp
2010 2.9% CN¥9.42 Million CN¥320.13 Million CN¥466.66 Million CN¥457.23 Million ▲ +39.6 pp
2009 -36.7% CN¥-112.73 Million CN¥307.17 Million CN¥427.41 Million CN¥540.13 Million ▲ +26.1 pp
2008 -62.8% CN¥-190.54 Million CN¥303.19 Million CN¥438.46 Million CN¥628.99 Million ▼ -52.4 pp
2007 -10.4% CN¥-31.26 Million CN¥299.61 Million CN¥505.81 Million CN¥537.07 Million ▲ +26.6 pp
2006 -37.0% CN¥-109.12 Million CN¥294.62 Million CN¥319.67 Million CN¥428.79 Million ▼ -24.2 pp
2005 -12.8% CN¥-37.09 Million CN¥289.64 Million CN¥241.15 Million CN¥278.24 Million ▼ -52.7 pp
2004 39.9% CN¥113.28 Million CN¥284.03 Million CN¥255.30 Million CN¥142.02 Million ▲ +36.7 pp
2003 3.2% CN¥2.83 Million CN¥88.44 Million CN¥142.11 Million CN¥139.28 Million ▼ -21.9 pp
2002 25.1% CN¥15.85 Million CN¥63.02 Million CN¥114.13 Million CN¥98.28 Million ▲ +11.7 pp
2001 13.4% CN¥5.47 Million CN¥40.67 Million CN¥116.26 Million CN¥110.80 Million —
pp = percentage points